Draft Genome Sequence of Bacillus velezensis CE2, Which Genetically Encodes a Novel Multicomponent Lantibiotic.

Campbell, Emily; Gerst, Michelle; Huang, B Carol; Kong, Nguyet; Weimer, Bart C; Yousef, Ahmed E

Campbell, Emily; Gerst, Michelle; Huang, B Carol; Kong, Nguyet; Weimer, Bart C; Yousef, Ahmed E.

Afiliación

Campbell E; Department of Food Science and Technology, The Ohio State University, Columbus, Ohio, USA.
Gerst M; Department of Microbiology, The Ohio State University, Columbus, Ohio, USA.
Huang BC; School of Veterinary Medicine, 100K Pathogen Genome Project, University of California Davis, Davis, California, USA.
Kong N; School of Veterinary Medicine, 100K Pathogen Genome Project, University of California Davis, Davis, California, USA.
Weimer BC; School of Veterinary Medicine, 100K Pathogen Genome Project, University of California Davis, Davis, California, USA.
Yousef AE; Department of Food Science and Technology, The Ohio State University, Columbus, Ohio, USA.

Microbiol Resour Announc ; 8(3)2019 Jan.

Article en En | MEDLINE | ID: mdl-30687828

RESUMEN

Bacillus velezensis CE2 produces potent antimicrobial compound(s). The draft genome sequence of the strain reported here is 4.1 Mb with a G+C content of 46.1%. Whole-genome sequencing revealed that the strain genetically encodes a novel multicomponent lantibiotic, velezensicidin.

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Microbiol Resour Announc Año: 2019 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google